Cargando…
Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice
Acute myeloid leukemia (AML) is a molecularly diverse malignancy with a poor prognosis, whose largest subgroup is characterized by somatic mutations in NPM1, the gene for Nucleophosmin1. These mutations, termed NPM1c, result in cytoplasmic dislocation of Nucleophosmin1 and are associated with distin...
Autores principales: | Vassiliou, George S., Cooper, Jonathan L., Rad, Roland, Li, Juan, Rice, Stephen, Uren, Anthony, Rad, Lena, Ellis, Peter, Andrews, Rob, Banerjee, Ruby, Grove, Carolyn, Wang, Wei, Liu, Pentao, Wright, Penny, Arends, Mark, Bradley, Allan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084174/ https://www.ncbi.nlm.nih.gov/pubmed/21441929 http://dx.doi.org/10.1038/ng.796 |
Ejemplares similares
-
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice
por: Mupo, A, et al.
Publicado: (2013) -
Nucleophosmin leukemogenic mutant activates Wnt signaling during zebrafish development
por: Barbieri, Elisa, et al.
Publicado: (2016) -
Monoclonal Antibodies against Nucleophosmin Mutants: Potentials for the Detection of Acute Myeloid Leukemia
por: Tan, Shi, et al.
Publicado: (2011) -
Genetic screens using the piggyBac transposon
por: Chew, Su Kit, et al.
Publicado: (2011) -
NUCLEOPHOSMIN MUTATION IS DOUBLE TROUBLE
por: Robinson, Richard
Publicado: (2008)